Cudc-907
Relapsed and/or Refractory Diffuse Large B-cell Lymphoma Including With Myc Alterations
Curis, Inc.Phase 2
—
Rating in progress
Cudc-907 in Relapsed and/or Refractory Diffuse Large B-cell Lymphoma Including With Myc Alterations is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.
Methodology v0.2 · Dormant